000			02072 a2200649 4500
005			20250516201920.0
264		0	_c20140604
008			201406s 0 0 eng d
022			_a1432-0851
024	7		_a10.1007/s00262-014-1528-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aKelderman, Sander
245	0	0	_aLactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cMay 2014
300			_a449-58 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIpilimumab
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aHeemskerk, Bianca
700	1		_avan Tinteren, Harm
700	1		_avan den Brom, Rob R H
700	1		_aHospers, Geke A P
700	1		_avan den Eertwegh, Alfonsus J M
700	1		_aKapiteijn, Ellen W
700	1		_ade Groot, Jan Willem B
700	1		_aSoetekouw, Patricia
700	1		_aJansen, Rob L
700	1		_aFiets, Edward
700	1		_aFurness, Andrew J S
700	1		_aRenn, Alexandra
700	1		_aKrzystanek, Marcin
700	1		_aSzallasi, Zoltan
700	1		_aLorigan, Paul
700	1		_aGore, Martin E
700	1		_aSchumacher, Ton N M
700	1		_aHaanen, John B A G
700	1		_aLarkin, James M G
700	1		_aBlank, Christian U
773	0		_tCancer immunology, immunotherapy : CII _gvol. 63 _gno. 5 _gp. 449-58
856	4	0	_uhttps://doi.org/10.1007/s00262-014-1528-9 _zAvailable from publisher's website
999			_c23622379 _d23622379